As fears grew over a widening Ebola outbreak in west Africa, it was an unlikely company to which the world turned for help: Japan’s Fujifilm.
A newcomer to the pharmaceutical industry, the Japanese rival of Eastman Kodak was thrust into global spotlight when its anti-influenza drug emerged as a potential treatment for Ebola patients.
“If requested, we are ready to quickly produce mass amounts,” said Shigetaka Komori, Fujifilm’s chief executive.
您已閱讀9%（446字），剩余91%（4525字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。